Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

NCT01548690 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Acute Liver Failure
Acute Liver Injury

Interventions

DRUG: Ornithine Phenylacetate

Sponsor

William Lee

Collaborators

[object Object]
[object Object]
[object Object]